Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBITDA (2020 - 2025)

Clene (CLNN) has 6 years of EBITDA data on record, last reported at -$8.8 million in Q3 2025.

  • For Q3 2025, EBITDA fell 10.63% year-over-year to -$8.8 million; the TTM value through Sep 2025 reached -$30.6 million, up 14.83%, while the annual FY2024 figure was -$39.5 million, 20.16% up from the prior year.
  • EBITDA reached -$8.8 million in Q3 2025 per CLNN's latest filing, down from -$7.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $28.9 million in Q3 2021 and bottomed at -$39.7 million in Q1 2021.
  • Average EBITDA over 5 years is -$7.7 million, with a median of -$7.9 million recorded in 2024.
  • Peak YoY movement for EBITDA: skyrocketed 380.36% in 2021, then tumbled 980.88% in 2023.
  • A 5-year view of EBITDA shows it stood at $4.5 million in 2021, then tumbled by 120.9% to -$931000.0 in 2022, then crashed by 980.88% to -$10.1 million in 2023, then crashed by 36.15% to -$13.7 million in 2024, then surged by 35.95% to -$8.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$8.8 million in Q3 2025, -$7.4 million in Q2 2025, and -$736000.0 in Q1 2025.